Volume 8 Issue 2 - International Biopharmaceutical Industry

Current Edition

Application Notes

The Science of Cell Line Development for Biologics: Improving Stability and Yield

Mammalian cell line development is essential to biologics manufacturing, ensuring stable, high-yield expression of therapeutic proteins. With expanding biologics pip...

17 July 2025 Application Notes | Volume 8 Issue 2

Continue Reading →

Volume 8 Issue 2

Harnessing the Power of Generative AI: Transforming Life Science Manufacturing

The life science industry faces the challenges of developing and delivering life-changing medicines at an accelerated pace, all while maintaining quality and safety ...

17 July 2025 Volume 8 Issue 2 | Editorial Archives

Continue Reading →

Volume 8 Issue 2

Building a Global Data Foundation for Scaling AI

AI use cases are rippling across commercial biopharma, helping companies make faster, more informed decisions. Yet almost 70% of top generative AI (GenAI) users cite...

17 July 2025 Volume 8 Issue 2 | Editorial Archives

Continue Reading →

Volume 8 Issue 2

Regulatory Impact Assessment is Obvious Next Target for GenAI, Experts Conclude

When anything changes to a product’s make-up or manufacture, a whole chain of events is triggered, starting with an assessment of the regulatory impact in each regul...

17 July 2025 Volume 8 Issue 2 | Editorial Archives

Continue Reading →

Volume 8 Issue 2

Avoiding the Domino Effect: How Smarter Temperature Control and Excursion Management Prevent Clinical Trial Disruptions

When investigational medicinal products (IMPs) are exposed to conditions outside of their approved storage range, sponsors need to be ready to act or risk the integr...

17 July 2025 Volume 8 Issue 2 | Editorial Archives

Continue Reading →